These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 11073754)

  • 1. Susceptibility testing for mycobacteria.
    Woods GL
    Clin Infect Dis; 2000 Nov; 31(5):1209-15. PubMed ID: 11073754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.
    Hoel T; Casals JB; Eng J
    APMIS; 1993 Jan; 101(1):27-32. PubMed ID: 8457323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility.
    Uslan DZ; Kowalski TJ; Wengenack NL; Virk A; Wilson JW
    Arch Dermatol; 2006 Oct; 142(10):1287-92. PubMed ID: 17043183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility testing of rapidly growing mycobacteria by microdilution - experience of a tertiary care centre.
    Set R; Rokade S; Agrawal S; Shastri J
    Indian J Med Microbiol; 2010; 28(1):48-50. PubMed ID: 20061764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multicenter evaluation of a newly developed microdilution test, brothMIC NTM to determine minimum inhibitory concentrations of antimicrobial agents for nontuberculous mycobacteria].
    Yamane N; Onaga S; Saitoh H; Toyoshima S; Shimojima M; Kawahara S; Takashima T; Yamashita T
    Rinsho Byori; 2002 Apr; 50(4):381-91. PubMed ID: 12014018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Standardization of laboratory tests for tuberculosis and their proficiency testing].
    Abe C
    Kekkaku; 2003 Aug; 78(8):541-51. PubMed ID: 14509226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro study of the susceptibility of mycobacteria to sulfonamides by the disc and percentage methods (author's transl)].
    Demoulin L; Médard M; Kellens J
    Pathol Biol (Paris); 1982 Apr; 30(4):201-5. PubMed ID: 7045778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibility to antimicrobial agents of rapidly growing mycobacteria].
    Ruiz-Aragón J; García-Agudo L; Flores S; Rodríguez MJ; Marín P; García-Martos P
    Rev Esp Quimioter; 2007 Dec; 20(4):429-32. PubMed ID: 18563216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
    Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI
    Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro drug susceptibility of Mycobacterium other than tubercle bacilli.
    Imwidthaya P; Komolpis P; Suthiravitayavaniz K; Rienthong S
    J Med Assoc Thai; 1990 Aug; 73(8):438-42. PubMed ID: 2262746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro susceptibility testing of nontuberculous mycobacteria to streptomycin, kanamycin and enviomycin].
    Tsukamura M
    Kekkaku; 1989 Sep; 64(9):557-62. PubMed ID: 2554046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae.
    Aono A; Morimoto K; Chikamatsu K; Yamada H; Igarashi Y; Murase Y; Takaki A; Mitarai S
    J Infect Chemother; 2019 Feb; 25(2):117-123. PubMed ID: 30447882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results].
    Tsukamura M; Yamori S
    Kekkaku; 1990 May; 65(5):349-57. PubMed ID: 2168003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical mycobacteriology. Drug susceptibility testing.
    Heifets LB
    Clin Lab Med; 1996 Sep; 16(3):641-56. PubMed ID: 8866184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria.
    Vera-Cabrera L; Brown-Elliott BA; Wallace RJ; Ocampo-Candiani J; Welsh O; Choi SH; Molina-Torres CA
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4027-9. PubMed ID: 17015632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sulfadimethoxine as a promising drug in the treatment of infections caused by Mycobacterium kansasii and Mycobacterium xenopi--differentiation between M. kansasii and M. marinum and between M. gordonae and M. scrofulaceum by the susceptibility testing to sulfadimethoxine].
    Tsukamura M
    Kekkaku; 1989 Apr; 64(4):313-7. PubMed ID: 2747117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Kuijper EJ
    Future Microbiol; 2014; 9(9):1095-110. PubMed ID: 25340838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.